Legislation and Supporting Documents Practice Resources Pharmacy Technicians Expanded Scope of Practice Forms & Pharmacy Signs Implementation of the December 2006 Pharmaceutical Act

Pharmacy Practice

The College of Pharmacists of Manitoba (formerly known as the “Manitoba Pharmaceutical Association”) continues to adapt the content on www.cphm.ca in order to reflect the December 2006 Pharmaceutical Act , implemented January 1, 2014. The documents on the website with “Manitoba Pharmaceutical Association” or “MPhA” have not been updated and may not be consistent with the current legislation. Questions on this content can be directed to the College office.


Legislation and Supporting Documents


A Guide to Pharmacy Practice in Manitoba

A Guide to Pharmacy Practice in Manitoba replaces Orientation to the New Practice Framework. The updated Guide outlines the legislation, standards of practice, practice directions and code of ethics which form a framework for daily pharmacy practice in our province.

The Pharmaceutical Act 

Manitoba Pharmaceutical Regulation

Manitoba Pharmaceutical Regulation, amendment (posted September 30, 2016) 

CPhM By-Laws to The Pharmaceutical Act 

Code of Ethics (January 1, 2014)     
The Code of Ethics governs the conduct of members, students, interns and owners. 

Prescription Drug Cost Assistance Act

Provincial Prescription Regulation Summary Chart (M3P and Non-M3P)

Prescription Drugs Payment of Benefits Regulation

Manitoba Drug Benefits and Interchangeability Formulary

Manitoba Drug Benefits and Interchangeability Formulary List

The Apology Act

The Fair Registration Practices Act

Non-Potable Intoxicating Substances, Stomach Bitters and Rubbing Alcohol Regulation

Non-Smokers Health Protection Amendment Act

Pharmaceutical (General Matters) Regulation (in which a pharmacist is designated as a practitioner) (posted March 4, 2014)

Personal Health Information Act and Regulations   

The Protection for Persons in Care Act

Minimum Pharmacy Policy and Procedures Manual Content

Workplace Safety and Health Act

The Public Health Act and Regulations


Food and Drugs Act & Regulations

Controlled Drugs and Substances Act
& Regulations

Narcotic Control Regulations

Health Canada Prescription Drug List


Prescribing Authority Table  

Clinical & Physician Assistants

Clinical & Physician Assistant: Prescribing Authority (updated November 2016)
For a list of Clinical and Physician Assistants, please click here.


For an updated list of Dentists, please click here.


The Midwifery Act

Medications & Devices that a Midwife May Prescribe & Administer (Schedule B to the Midwifery Regulations of The Midwifery Act)

For a list of Midwives, please click here.


Prescribing Authority for Pharmacists

Available Drugs for Prescribing under Schedule 3 to the Manitoba Pharmaceutical Regulation


For the Physician Directory, Currently Licensed and Practising in the Province please click here .

Registered Nurses (Extended Practice)

RN(EP) (Extended Practice Registered Nurses) and NP (Nurse Practitioners)

have expanded prescriptive authority

View the CRNM Nurse Check (Extended Practice)

Letter to Manitoba Pharmacists from CRNM.


For a list of Veterinarians, please click here.


Optometrists Prescribing Authority (June 4, 2015)

Optometrists Drug List (Schedule A) 

To verify an Optometrist's therapeutic licence, please click here .

Standards of Practice and Practice Directions

A practice direction is a written statement made by Council for the purpose of giving direction to members and owners about the conduct of their practice and pharmacy operations. Compliance with approved practice directions is required under The Pharmaceutical Act .    

Practice Directions Policy Statement

National Association of Pharmacy Regulatory Authorities (NAPRA) Model Standards 

The following pharmacy practice standards were developed by the National Association of Pharmacy Regulatory Authorities (NAPRA). Following member consultation, as outlined in the Practice Directions Policy Statement, the Practice Directions listed below were approved by College Council.

NAPRA Model Standards for Pharmacy Compounding of Non-Sterile Preparations

NAPRA Model Standards for Pharmacy Compounding of Non-Sterile Preparations Guidance Document*

NAPRA Model Standards for Pharmacy Compounding of Non-Hazardous Sterile Preparations

NAPRA Model Standards for Pharmacy Compounding of Hazardous Sterile Preparations *

Pharmacy Practice Management Systems: Requirements to Support NAPRA's "Model Standards of Practice for Canadian Pharmacists" 

*For more information on the current compounding guidelines and the implementation schedule and deadlines for Manitoba compounding pharmacies for the NAPRA Model Standards for Pharmacy Compounding of Non-Hazardous and Hazardous Sterile Preparations, please the the following section titled 'Pharmacy Compounding.'

Pharmacy Compounding

The current standards for pharmacy compounding in Manitoba are as follows:

With a stepwise approach, the College will replace the Extemporaneous Compounding Guideline and the Guidelines on Sterile Production in Pharmacies and Handling and Disposal of Hazardous Pharmaceuticals with a suite of model pharmacy compounding standards developed by the National Association of Pharmacy Regulatory Authorities (NAPRA). Please see the following section for more information.

NAPRA Model Standards for Pharmacy Compounding of Non-Hazardous and Hazardous Sterile Preparations

On February 6, 2017, College Council approved an implementation schedule for the NAPRA Standards for Pharmacy Compounding of Non-hazardous and Hazardous Sterile Preparations with the following motion:

Council approved a phased-in implementation schedule, with the first implementation requirement date of January 1, 2019, with the expectation for total compliance throughout Manitoba by January 1, 2021, for the NAPRA Model Standards for the Compounding of Non-Hazardous Sterile Preparations and the Compounding of Hazardous Sterile Preparations.

To review the NAPRA model standards for pharmacy compounding, please visit the following links:

All pharmacies engaged in non-hazardous and/or hazardous sterile preparation are required to transition to the NAPRA Model Standards according to the implementation schedules below:  

NAPRA Model Standards for Pharmacy Compounding of Non-Sterile Preparations

On December 10, 2018, College Council approved an implementation schedule for the NAPRA Standards for Pharmacy Compounding of Non-Sterile Preparations.

NAPRA Guidance document for pharmacy compounding of non-sterile preparations

NAPRA Model standards for Pharmacy compounding of non-sterile preparations.

Interim Standards of Practice and Practice Directions 

In 2011, Council made the decision to accept the then current Standards of Practice documents as practice directions under the new legislation in order for the Standards of Practice Committee to focus on the creation of new practice directions that were needed under the new regulations and expanded scope of practice for pharmacists. The Standards of Practice listed below are now considered "practice directions" and will be reviewed by the Standards of Practice Committee in due course. 

International Prescription Service Pharmacy Standards of Practice

Hospital Standards of Practice and Guidelines [practice direction] 

Personal Care Home - Long-Term Care Standards of Practice [practice direction]

Approved Standards of Practice and Practice Directions

After a series of Special General Meetings and opportunities for member feedback, as per the Practice Directions Policy Statement, the following practice directions have been approved by Council.

Adaptation of a Prescription
[effective January 1, 2014]

Administration of Drugs including Vaccines [Standard of Practice #5 [updated and posted June 25, 2014]

Advertising in Manitoba Pharmacies [effective February 8, 2016]

Alternate Verification Program: Drug Packaging [effective April 24, 2015]

      All current Alternate Verification Programs must be replaced by a College approved Pharmacy Technician Final Check Process by October 31, 2019 as set by Council. 

Central Fill [effective April 11, 2014]

Clinical Practice Pharmacies Practice Direction [effective October 5, 2015]

Conscientious Objection [effective July 27, 2018]

Delegation of Dispensing to Other Health Professionals Practice Direction
[effective December 18, 2015]

Drug Distribution Practice Direction [effective July 8, 2016]

Ensuring Patient Safety [updated document is effective March 13, 2015]

Exempted Codeine Practice Direction [effective February 1, 2016]

Aids to the Exempted Codeine Practice Direction: 

Medication Incidents and Discrepancies Practice Direction [effective July 8, 2016]

Lock and Leave Component [effective January 1, 2014]

Manitoba Prescribing Practices Program (M3P) Information Entered into DPIN [effective January 1, 2014]

Pharmacy Facilities [Standard of Practice #15] [effective December 10, 2018]

Patient Counselling [effective October 10, 2014]

Patient Profiles [effective October 10, 2014]

Permanent and Temporary Pharmacy Closure   [effective July 4, 2014]
Prescribing [Effective January 1, 2014] (Most Recent Revision date: December 2, 2019)

Prescribing and Dispensing [Standard of Practice #4] [effective January 1, 2014]

Records and Information [Standard of Practice #12] [effective January 1, 2014]

Referring a Patient

Refill History Recording System [effective February 13, 2015]

Sale of NAPRA Schedule 2 Drugs [effective January 1, 2014] 

Sale of NAPRA Schedule 3 Drugs [effective January 1, 2014]

Secondary Hospital Services Component Practice Direction [effective December 18, 2015]

Termination of Patient Relationship [Standard of Practice #11] [effective July 4, 2014]

Test Interpretation [Standard of Practice #7] [effective January 1, 2014] (Most Recent Revision date: December 2, 2019)

Test Orders [effective October 15, 2018]

Transfer of Patient care [Standard of Practice #10] [effective January 1, 2014]

Supervision [effective July 4, 2014]


Practice Guidelines

On April 25, 2014, Council passed a motion to accept the document’s proposed requirements for the PPMS used by pharmacy professionals for compliance in Manitoba pharmacies by January 1, 2016, in conjunction with NAPRA’s effective date. The following guidelines are approved by Council. They are policies and practice indicators developed under the old legislation and are still valid under the new legislation. These documents will be reviewed by Council in due course.

Guidelines for Pharmacists Dispensing Mifegymiso in Manitoba

Guidelines for pharmacy licence holders wanting to use more than one name for their pharmacy 

Guidelines on sterile production in pharmacies, and handling and disposal of hazardous pharmaceuticals 

Narcotic and Controlled Drug Accountability Guidelines

Needle Stick Injury Guideline (added June 30, 2015)

Position Statement on Non-Medical (Recreational) Cannabis

Position Statement on Injection of Neuromodulators and Dermal Fillers

Practice Guideline for Professional Boundaries in Therapeutic Relationships

Procedures in the Event of a Robbery or Burglary
[updated December 2014]

Satellite  Pharmacy Component Criteria

Self-Testing Product Guidelines

Opioid Agonist Therapy Guidelines (Updated December 2, 2019)

For updates regarding the guidelines, please refer to the July 10, 2020 Friday Five.

The Opioid Replacement Therapy Guidelines has recently been updated and renamed the Opioid Agonist Therapy Guidelines for Manitoba Pharmacists (OAT Guidelines). The new title reflects current terminology used in healthcare practice as well as the change in the interprofessional educational ORT 101 Workshop to the OAT 101 Workshop. The OAT workshop is required education for at least one pharmacist in each pharmacy that is dispensing methadone or buprenorphine.

Information added to the guidelines include:

  • Additional information related to new Health Canada exemptions for community health facilities. The exemptions allow for nursing staff to possess, administer and transport methadone and buprenorphine. Also allows pharmacies to supply these medications to community health facilities with nursing staff.
  • Action in cases of overdose due to dosing error
  • Information on the College of Physician and Surgeons document on Take Home Dosing Recommendations for Buprenorphine
  • Addition of a Centre for Addiction and Mental Health course for buprenorphine training
  • Additional clarification on witnessed ingestion, deliveries, pregnancy and breastfeeding, M3P total dose requirement and secure storage of methadone doses

Pharmacists dispensing OAT must review the updated OAT Guidelines.

OAT Training and Education

At least one pharmacist within a pharmacy dispensing methadone and/or buprenorphine must be extensively knowledgeable on OAT. The pharmacist with specialized training at a pharmacy is responsible for training all pharmacists who will be dispensing methadone and/or buprenorphine. Please see the OAT Guidelines for more information on the accepted training programs. It is strongly recommended that all pharmacists dispensing methadone and/or buprenorphine/naloxone also complete the theoretical training, “Opioid Agonist Therapy 101: An introduction to clinical practice”, to gain additional insight on the interprofessional collaborative approach to opioid replacement therapy. All pharmacists providing OAT services must review the Opioid Replacement Therapy Guidelines for Manitoba Pharmacists.

If you are interested in taking an Opioid Agonist Therapy 101 workshop, the University of Manitoba Continuing Professional Development (CPD) Department is now accepting applicants. Please visit the Upcoming Professional Development Opportunities page to see the dates this workshop is available.

Additional recommended readings for pharmacists dispensing opioid replacement therapy include:

For additional resources on dispensing and administering naloxone please review the section below.


Manitoba, along with the rest of Canada, has seen a rise in the number of opioid overdose deaths in recent years. As a result, some pharmacies in the province have begun selling naloxone kits and providing education to people and organizations in need of this life-saving drug that can temporarily reverse the effects of an overdose.

The College encourages all pharmacies to carry naloxone kits to support the province-wide effort to address the opioid crisis. Pharmacies selling naloxone must comply with the Guidelines for Pharmacists Selling Naloxone as a Schedule II Drug   (Guidelines).

Please review the Guidelines for more information about selling naloxone, including:

  • Training requirements

  • Relevant practice directions

  • Patient counselling

If your pharmacy carries naloxone kits and you would like to be added to the publically available College listing of Pharmacies Carrying Naloxone Kits , please email your pharmacy's name, address, and telephone number to Gus Gottfred, Communications Coordinator, at ggottfred@cphm.ca. For additional information and resources on opioid overdose and naloxone, please see the resources below:

College of Pharmacists of Manitoba Resources*:

Naloxone Listing - College of Pharmacists of Manitoba   

College of Pharmacists of Manitoba Checklist for Naloxone Injection Training

College of Pharmacists of Manitoba Checklist for Naloxone Nasal Spray

Naloxone Brochure for Ampoules (black and white)

Naloxone Brochure for Ampoules (colour)

College of Pharmacists of Manitoba Naloxone FAQ 

University of Waterloo, School of Pharmacy Resources

Naloxone Administration  (by injection) (video) 

Naloxone Administration  (by nasal spray) (video) 

5 Things to Know About Naloxone  (video) 

Giving Naloxone  (video) 

External Resources:

Overdose and Prevention Response Training Manual

Street Connections: Overdose

Naloxone Saves Lives, Hello Cool World  (video)

Manitoba Addictions Knowledge Exchange

*The Naloxone educational information included above was developed through a partnership between the College of Pharmacists of BC, the BC Centre of Disease Control and the Province of BC's Ministry of Health.

This work is licensed under a  Creative Commons Attribution-ShareAlike 4.0 International License .

The naloxone educational resources above are available under the Creative Commons Attribution-ShareAlike License to use and remix as needed to help provide patients and pharmacy professionals with important information on the use of this life saving drug. 

  Medical Assistance In Dying (MAID) (formerly physician assisted dying)

Notice to Pharmacy Managers and Pharmacists

Emergency Contraception 

Emergency Contraception Care Guidelines 

Duty of Pharmacists to Report Issues in the Course of Counseling and Providing Emergency Contraception Care for Minors

Manitoba Prescribing Practices Program (M3P)

Manitoba Prescribing Practices Program (M3P Information Entered into DPIN Practice Direction 

M3P Questions and Answers [updated August, 2016] 

List of Drugs Covered by the Multiple Prescription Program  (Updated December 2019)

Removal of lisdexamfetamine (Vyvanse®), methylphenidate OROS (Concerta®), and methylphenidate MLR (Biphentin®) from the M3P Program (October 24, 2018)

Regulations Governing the Multiple Prescription Program 

Prescriptions from other Provinces 

Newsletter Items Relating to M3P 

M3P DPIN Entry Information 

Emergency Preparedness

Emergency Preparedness Resource Kit for Pharmacists

Field Office Information

Permanent and Temporary Pharmacy Closure [effective July 4, 2014]

New Pharmacy Opening package

Procedures in the Event of a Robbery or Burglary

Prescription Forgeries [from the Summer 2013 Newsletter]

PHIA Pledge of Confidentiality

Distance Care IPS Disclaimer

Manitoba Medications Return Program Website

Manitoba Medication Return Program FAQ [updated November 3, 2014]

Frequently Asked Questions: Patient Record Destruction  

Changing the hours of operation of a pharmacy

Joint Statements

Healthcare professionals from various disciplines, including pharmacy, are often jointly involved in the care of a common patient even though individual professionals are not in direct contact with one another. Joint statements are developed between healthcare professions to maintain patient safety and ensure collaborative patient care. 

Prescribing Practices: Doctor/Pharmacist Relationships  (updated to reflect the requirement for retention of records for five years)

Electronic Transmission of Prescriptions

Facsimile Transmission of Prescriptions

Facsimile Transmission of Prescriptions Template  (pdf template)

Facsimile Transmission of Prescriptions Template  (word template)

Interprofessional Collaborative Care Practice Direction

Q and A: Electronic and Facsimile Transmission of Prescriptions  

Rural, Remote and Underserved Populations: Access to Prescribed Medications